Zenas Biopharma Inc (ZBIO)

$31.80 +7.90 (33.08%)
Market Cap 1.01B
Revenue (ttm) 5.00M
Net Income (ttm) -156.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,139.80%
Debt to Equity Ratio 0.00
Volume 3,136,500
Avg Vol 327,760
Day's Range N/A - N/A
Shares Out 42.11M
Stochastic %K 42%
Beta N/A
Analysts Strong Sell
Price Target $35.50

Company Profile

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company also develops ZB002, an anti-TNFa monoclonal anti...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 271 2954
Address:
852 Winter Street, Suite 250, Waltham, United States
Gbang77
Gbang77 Oct. 27 at 7:02 PM
$ZBIO Out @$32.42 💰💰💰
0 · Reply
DesertBullTrader
DesertBullTrader Oct. 27 at 6:01 PM
$ZBIO any chance Momentum algos enter ???
0 · Reply
topstockalerts
topstockalerts Oct. 27 at 5:39 PM
$ZBIO buyers stepping in.. ✅
0 · Reply
Stock_Catcher
Stock_Catcher Oct. 27 at 5:12 PM
$ZBIO all day grinder nice.
0 · Reply
DesertBullTrader
DesertBullTrader Oct. 27 at 5:10 PM
$ZBIO why no volume??
0 · Reply
StockKing8732
StockKing8732 Oct. 27 at 4:00 PM
$ZBIO look for the 40 push to 80s
2 · Reply
topstockalerts
topstockalerts Oct. 27 at 3:57 PM
$ZBIO It wants to move higher..
0 · Reply
SocioCobb
SocioCobb Oct. 27 at 3:47 PM
$ZBIO
0 · Reply
FALCON765
FALCON765 Oct. 27 at 3:46 PM
$ZBIO 👈 VERY GOOD NEWS ! GET READY FOR GOOD MOVE !💥 GOT TARGET 52 NOW !
0 · Reply
IsabellaDC
IsabellaDC Oct. 27 at 3:16 PM
Stocks at an all-time high. How many do you own? :) $KLAC $MPWR $RNA $ZBIO $FTAI and so on..
0 · Reply
Latest News on ZBIO
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis

Oct 27, 2025, 7:05 AM EDT - 13 hours ago

Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis

Zenas BioPharma: Two Late-Stage Catalysts And A $2B InnoCare Deal

Oct 9, 2025, 8:00 AM EDT - 18 days ago

Zenas BioPharma: Two Late-Stage Catalysts And A $2B InnoCare Deal

Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug

Oct 8, 2025, 6:04 AM EDT - 19 days ago

Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug

Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple Sclerosis

Oct 8, 2025, 5:00 AM EDT - 19 days ago

Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple Sclerosis

Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million

Sep 2, 2025, 7:05 AM EDT - 7 weeks ago

Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million

RPRX

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

Aug 26, 2025, 7:05 AM EDT - 2 months ago

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

Zenas BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Aug 12, 2025, 7:05 AM EDT - 2 months ago

Zenas BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Zenas Biopharma: A Risky Buy On Upcoming Data Readouts In IgG4, MS

Jul 28, 2025, 1:42 PM EDT - 3 months ago

Zenas Biopharma: A Risky Buy On Upcoming Data Readouts In IgG4, MS

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jun 20, 2025, 4:15 PM EDT - 4 months ago

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

FINAL ALERT NOTICE - ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

Jun 16, 2025, 3:44 AM EDT - 4 months ago

FINAL ALERT NOTICE - ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

Jun 15, 2025, 10:44 AM EDT - 4 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

Jun 12, 2025, 6:17 PM EDT - 4 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

Jun 11, 2025, 10:24 AM EDT - 4 months ago

ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

May 31, 2025, 8:55 AM EDT - 5 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

Zenas BioPharma to Present at the Jefferies Global Healthcare Conference

May 29, 2025, 7:05 AM EDT - 5 months ago

Zenas BioPharma to Present at the Jefferies Global Healthcare Conference

Reminder from Cohen Milstein: Zenas BioPharma (ZBIO) Lead Plaintiff Deadline in ZBIO Stock Drop Suit Approaching

May 15, 2025, 3:10 PM EDT - 5 months ago

Reminder from Cohen Milstein: Zenas BioPharma (ZBIO) Lead Plaintiff Deadline in ZBIO Stock Drop Suit Approaching

Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates

May 15, 2025, 7:05 AM EDT - 5 months ago

Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Zenas BioPharma Investors: Cohen Milstein Highlights June 16 Deadline to Seek Lead Plaintiff Role in Securities Lawsuit

May 13, 2025, 4:20 PM EDT - 5 months ago

Zenas BioPharma Investors: Cohen Milstein Highlights June 16 Deadline to Seek Lead Plaintiff Role in Securities Lawsuit

Cohen Milstein Reminds Zenas BioPharma (ZBIO) Investors of Opportunity to Lead Securities Fraud Suit

May 5, 2025, 2:48 PM EDT - 6 months ago

Cohen Milstein Reminds Zenas BioPharma (ZBIO) Investors of Opportunity to Lead Securities Fraud Suit

Cohen Milstein Seeks Investors to Lead Suit to Hold Zenas BioPharma (ZBIO) Accountable for IPO-Related Fraud

May 1, 2025, 3:08 PM EDT - 6 months ago

Cohen Milstein Seeks Investors to Lead Suit to Hold Zenas BioPharma (ZBIO) Accountable for IPO-Related Fraud

Cohen Milstein Calls on Zenas BioPharma (ZBIO) Investors to Act Following Significant Post-IPO Losses

Apr 22, 2025, 10:37 AM EDT - 6 months ago

Cohen Milstein Calls on Zenas BioPharma (ZBIO) Investors to Act Following Significant Post-IPO Losses

Zenas Biopharma Investors Urged to Contact Cohen Milstein After Post-IPO Losses

Apr 21, 2025, 12:33 PM EDT - 6 months ago

Zenas Biopharma Investors Urged to Contact Cohen Milstein After Post-IPO Losses

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Zenas BioPharma, Inc. (ZBIO)

Apr 17, 2025, 8:00 PM EDT - 6 months ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Zenas BioPharma, Inc. (ZBIO)

Gbang77
Gbang77 Oct. 27 at 7:02 PM
$ZBIO Out @$32.42 💰💰💰
0 · Reply
DesertBullTrader
DesertBullTrader Oct. 27 at 6:01 PM
$ZBIO any chance Momentum algos enter ???
0 · Reply
topstockalerts
topstockalerts Oct. 27 at 5:39 PM
$ZBIO buyers stepping in.. ✅
0 · Reply
Stock_Catcher
Stock_Catcher Oct. 27 at 5:12 PM
$ZBIO all day grinder nice.
0 · Reply
DesertBullTrader
DesertBullTrader Oct. 27 at 5:10 PM
$ZBIO why no volume??
0 · Reply
StockKing8732
StockKing8732 Oct. 27 at 4:00 PM
$ZBIO look for the 40 push to 80s
2 · Reply
topstockalerts
topstockalerts Oct. 27 at 3:57 PM
$ZBIO It wants to move higher..
0 · Reply
SocioCobb
SocioCobb Oct. 27 at 3:47 PM
$ZBIO
0 · Reply
FALCON765
FALCON765 Oct. 27 at 3:46 PM
$ZBIO 👈 VERY GOOD NEWS ! GET READY FOR GOOD MOVE !💥 GOT TARGET 52 NOW !
0 · Reply
IsabellaDC
IsabellaDC Oct. 27 at 3:16 PM
Stocks at an all-time high. How many do you own? :) $KLAC $MPWR $RNA $ZBIO $FTAI and so on..
0 · Reply
Noble_27
Noble_27 Oct. 27 at 3:09 PM
$ZBIO Am I reading this right? A short float of over 90%
0 · Reply
kellyc09
kellyc09 Oct. 27 at 2:58 PM
$ZBIO Getting back to where it was pre market. Beautiful ride after selling off to $25.
0 · Reply
Chrille20
Chrille20 Oct. 27 at 2:43 PM
$ZBIO ⏳
0 · Reply
TA_Kongen
TA_Kongen Oct. 27 at 2:38 PM
$ZBIO Watching this creeper play here.
0 · Reply
Djdanny
Djdanny Oct. 27 at 2:31 PM
$ZBIO big green leg?
0 · Reply
KF2015
KF2015 Oct. 27 at 1:55 PM
$ZBIO I'm in for 50% gain eod.
0 · Reply
Gbang77
Gbang77 Oct. 27 at 1:55 PM
$ZBIO $28 average
0 · Reply
TheDizPlinTrader
TheDizPlinTrader Oct. 27 at 1:54 PM
$ZBIO 🧫 1H Levels Biotech names see increased volatility ahead of conference catalysts. Price: $26.20 Support: $24.40 Resistance: $26.60 (Possibly) Momentum firm—buyers aiming for $26.60.
0 · Reply
kellyc09
kellyc09 Oct. 27 at 1:39 PM
$ZBIO I saw $31 pre market and looked strong, need some volume for another push.
0 · Reply
_www_larval_com_
_www_larval_com_ Oct. 27 at 1:39 PM
$CLIK -12%[52%] $ZBIO -10%[3%] $NTLA 9%[-38%] $UUUU 5%[-7%] $ALTS -5%[3%] most notable movement within the first minutes of trading.
0 · Reply
topstockalerts
topstockalerts Oct. 27 at 1:32 PM
$ZBIO It wants to move higher..
0 · Reply
Stock_Catcher
Stock_Catcher Oct. 27 at 1:23 PM
$ZBIO perking
0 · Reply